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Artiﬁcial musk compounds are widely used as
inexpensive fragrances and ﬁxatives in personal
care products, including detergents, cleaning
agents, air fresheners, and cosmetic products
(names and structures are shown in Table 1).
The worldwide production of musks increased
from about 7,000 to 8,000 metric tons/year
between 1987 and 1996, with a concurrent
production shift from nitromusks to polycyclic
musks (Rimkus 1999). The most widely used
polycyclic musk is Galaxolide (HHCB), fol-
lowed by Tonalide (AHTN) (Rimkus 1999),
and production of these two polycyclics was
about 1,800 metric tons in 2000 in Europe,
whereas production of other polycyclic musks
was < 20 metric tons (Kupper et al. 2004).
Musk xylene (MX) is the most common
nitromusk, but use was discontinued in Japan
and a voluntary ban is in force in Germany
(Käfferlein et al. 1998). Use is still high in the
United States, although it is banned in prod-
ucts with a risk of oral uptake (e.g., lipsticks).
Toxicologic data have not suggested severe
health risks associated with artificial musks,
although long-term carcinogenic effects cannot
be ruled out (Api et al. 2004; Frosch et al.
1995; Käfferlein and Angerer 2001; Schmeiser
et al. 2001); there is also concern about accu-
mulation in adipose tissue, blood plasma, and
breast milk (Käfferlein and Angerer 2001;
Liebl and Ehrenstorfer 1993; Ott et al. 1999;
Rimkus and Wolf 1996).
More than two decades ago Yamagishi
et al. (1981, 1983) reported the presence of
musks in the aquatic environment and biota
in Japan, leading to similar investigations in
Europe and North America (Balk and Ford
1999a; Bester et al. 1998; Draisci et al. 1998;
Gatermann et al. 2002; Käfferlein et al. 1998;
Kallenborn et al. 1999; Osemwengi and
Steinberg 2001; Paasivirta et al. 2002; Peck
and Hornbuckle 2004; Ricking et al. 2003;
Rimkus 1999; Rimkus et al. 1997, 1999;
Rimkus and Wolf 1995; Tas and Balk 1997;
Tas et al. 1997). These studies show that syn-
thetic musks are widespread in marine and
freshwater environments and bioaccumulate
to a high degree in fish and invertebrates.
Because acute and chronic toxicity thresholds
for musks in invertebrate and ﬁsh species are
much higher than the environmentally meas-
ured levels (Balk and Ford 1999b; Behechti
et al. 1998; Breitholtz et al. 2003; Chou and
Dietrich 1999b; Wollenberger et al. 2003),
the environmental risks posed by musks are
assumed to be low (Balk et al. 2001). Musks
show low binding afﬁnity to estrogen recep-
tors, and their environmental impact as
endocrine disruptors through this pathway is
also regarded as low (Bitsch et al. 2002; Chou
and Dietrich 1999a), although indirect
endocrine effects such as inhibition of hor-
mone synthesis (Kester et al. 2000; Sanderson
et al. 2001) have not been examined.
However, it has been proposed that
pharmaceutical and personal care products
(PPCPs), a vast group of environmental
contaminants including the artificial musks,
might affect organisms through interference
with multidrug/multixenobiotic resistance
(MDR/MXR) efﬂux transporters (Daughton
and Ternes 1999; Epel and Smital 2001;
Smital et al. 2004). The activity of these
transporters provides a ﬁrst line of defense to
prevent accumulation of xenobiotics in cells.
Inhibition of this cellular defense mechanism
increases the sensitivity of cells to xenobiotics
by permitting normally excluded toxicants to
enter the cell (Epel 1998; Kurelec 1992).
The transporter proteins responsible for
MXR include P-glycoprotein (P-gp), multi-
drug-resistance protein (MRP), and other
members of the ABC (ATP-binding cassette)
family of transport proteins. A characteristic
feature of these efﬂux transporters is afﬁnity for
a diverse array of substrates. For instance, P-gp
acts on a large number of chemically unrelated
substrates whose common properties are small
size, moderate hydrophobicity, and positively
charged domains (Bain et al. 1997). Although
this low speciﬁcity may provide an advantage
by enabling the system to cope with “new”
chemicals (e.g., environmental pollutants), a
disadvantage is that the transporter capacity is
more easily saturated in the presence of many
substrates, and its protective role can then be
lost. This subversion of the MXR defense by
multiple substrates or inhibitors of efﬂux trans-
porters is referred to as chemosensitization,
and compounds that cause this behavior are
referred to as chemosensitizers (Epel 1998;
Kurelec 1997; Smital and Kurelec 1998b). We
hypothesized that the synthetic musks, which
are small-molecular-weight, moderately
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Cellular Xenobiotic Defense Systems Mediated by Multidrug Transporters
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Synthetic musk compounds, widely used as fragrances in consumer products, have been detected in
human tissue and, surprisingly, in aquatic organisms such as ﬁsh and mollusks. Although their per-
sistence and potential to bioaccumulate are of concern, the toxicity and environmental risks of these
chemicals are generally regarded as low. Here, however, we show that nitromusks and polycyclic
musks inhibit the activity of multidrug efﬂux transporters responsible for multixenobiotic resistance
(MXR) in gills of the marine mussel Mytilus californianus. The IC10 (concentration that inhibits
10%) values for the different classes of musks were in the range of 0.09–0.39 µM, and IC50 values
were 0.74–2.56 µM. The immediate consequence of inhibition of efﬂux transporters is that nor-
mally excluded xenobiotics will now be able to enter the cell. Remarkably, the inhibitory effects of
a brief 2-hr exposure to musks were only partially reversed after a 24- to 48-hr recovery period in
clean seawater. This unexpected consequence of synthetic musks—a long-term loss of efﬂux trans-
port activity—will result in continued accumulation of normally excluded toxicants even after
direct exposure to the musk has ended. These findings also point to the need to determine
whether other environmental chemicals have similar long-term effects on these transporters. The
results are relevant to human health because they raise the possibility that exposure to common
xenobiotics and pharmaceuticals could cause similar long-term inhibition of these transporters and
lead to increased exposure to normally excluded toxicants. Key words: chemosensitizers, fragrances,
MDR, multidrug resistance, multixenobiotic resistance, MXR, Mytilus californianus, nitromusks,
polycyclic musks. Environ Health Perspect 113:17–24 (2005). doi:10.1289/ehp.7301 available via
http://dx.doi.org/ [Online 30 September 2004]hydrophobic compounds, might be such
chemosensitizers, and preliminary studies
indeed showed inhibition of efﬂux transporters
in gill tissues of a marine mussel (Luckenbach
et al. 2004).
In this article we describe the inhibitory
potencies of six artificial musk compounds
and report the remarkable ﬁnding of contin-
ued inhibition of transport activity for
24–48 hr after a short (2 hr) exposure to
musks. Although of low toxicity themselves,
musks could therefore enhance toxicity of
other compounds by blocking the MXR
defense system. These results strongly afﬁrm
the hypothesis of Kurelec and collaborators,
that indirect effects of environmental chemi-
cals as efflux transporter chemosensitizers
could be of major importance (Epel 1998;
Kurelec 1995, 1997; Smital and Kurelec
1998b), but, additionally, our results indicate
that the effects of chemosensitizers might
continue long after the exposure event.
Materials and Methods
Chemicals. Musk ketone (MK), MX,
HHCB (1,3,4,6,7,8-hexahydro-4,6,6,7,8,
8-hexamethyl-cyclopenta-γ-[2]-benzopyran),
and Celestolide (ADBI; 4-acetyl-1,1-dimethyl-
6-tert-butylindane) were gifts from
International Flavors & Fragrances Inc. (IFF;
Union Beach, NJ); AHTN (7-acetyl-
1,1,3,4,4,6-hexamethyl-1,2,3,4-tetrahydron-
aphthalene) was obtained from Bush Boake
Allen Inc. (Jacksonville, FL); and Traseolide
(ATII; 5-acetyl-1,1,2,6-tetramethyl-3-isopropy-
lindane) was obtained from Quest International
(Mount Olive, NJ). Rhodamine B, (±)-vera-
pamil hydrochloride, and quinidine were pur-
chased from Sigma Chemical Company (St.
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Table 1. Names, CAS numbers, formulas, structures, molecular weights, and log Kow values for artiﬁcial musks and MXR model substrates and inhibitors.
Chemical and trade names CAS No. Formula Structure Molecular weight Log Kow
Musk xylene (MX) 81–15–2 C12H15N3O6 297.3 4.9a
1-tert-Butyl-3,5-dimethyl-2,4,6-trinitrobenzene
Musk ketone (MK) 81–14–1 C14H18N2O5 294.3 4.3a
1-tert-Butyl-3,5-dimethyl-2,6-dinitro-4-acetylbenzene
Galaxolide (HHCB) 1222–05–5 C18H26O 258.4 5.9a
1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethyl-
cyclopenta-γ-[2]-benzopyran
Celestolide, Crysolide(ADBI) 13171–00–1 C17H24O 244.4 5.9a
4-Acetyl-1,1-dimethyl-6-tert-butylindane
Tonalide, Tetralide, Fixolide (AHTN) 21145–77–7 C18H26O 244.4 5.7a
7-Acetyl-1,1,3,4,4,6-hexamethyl-tetrahydronaphthalene
Traseolide(ATII) 68140–48–7 C18H26O 258.4 6.3a
5-Acetyl-1,1,2,6-tetramethyl-3-isopropylindane
Quinidine 56–54–2 C20H24N2O2 324.4 2.8b
Verapamil 52–53–9 C27H38N2O4 454.6 4.5b
Rhodamine B 81–88–9 C28H31ClN2O3 479.0 1.5c
aData from Balk et al. (2001). bData from Wang et al. (2003). cData from Liu (2004).
NO2
NO2
NO2
NO2
NO2
O
O
O
O
O
H
H
H
H N
O
N
N
O
O O
O
NN O
O
CI
HO
NLouis, MO). Purity of MK, MX, verapamil,
and quinidine was ≥ 99%. Purity data were
not available for the other musk compounds
used. Stocks of rhodamine B in ultrapure water
and ethanol stocks of the musks, verapamil,
and quinidine were stored in glass ﬂasks at 4°C
in the dark.
Animals and tissue preparation. California
mussels (Mytilus californianus Conrad, 1837),
with valve lengths ranging from 70 to 95 mm,
were collected from the rocky intertidal zone at
Hopkins Marine Station (Paciﬁc Grove, CA)
and maintained in tanks with running seawater
(approximately 15°C) for at least 24 hr and no
longer than 2 weeks before experiments.
Experiments were performed with gill tissue,
which shows high efflux transporter activity
(Cornwall et al. 1995).
The mussels were opened by cutting
through the adductor muscles with a sharp
knife, and the gills were excised with ﬁne scis-
sors and placed in filtered seawater (FSW;
15°C). Each gill consists of two tissue lobes,
which were separated at their dorsal connec-
tion. To obtain tissue pieces of equal size, der-
matology biopsy punches (Acuderm, Fort
Lauderdale, FL) were used to excise disks
(diameter, 5 mm) from the tissue lobes. The
tissue disks that result from this procedure con-
sist of a double layer of lamellae (descending
and ascending arm) that are connected by
interlamellar tissue bridges. Approximately
55–70 disks per individual were obtained from
mussels of the size used for these experiments.
Mucus was removed from the gills with forceps
before preparing the disks; the tissue disks were
ﬂushed and kept in FSW until use.
The sex of each animal was determined
from visual inspection of gametes, which are
clearly distinguishable by shape (White
1937). A piece of gonad tissue was dipped
into a droplet of seawater on a microscope
slide, covered with a cover slip, and examined
under a light microscope equipped with phase
contrast at 400×.
Competitive substrate/transporter inhibi-
tion assay and long-term inhibition. The fluo-
rescent dye rhodamine B was used as an
indicator of efflux transporter activity.
Inhibition of transporter activity by a test
compound is indicated by increased fluores-
cence due to higher accumulation of rho-
damine B in the cell (Neyfakh 1988). Test
solutions were prepared in FSW with 1 µM
rhodamine B. Stocks of the test compounds
dissolved in ethanol were added to FSW to
the desired concentrations, and all solutions
were adjusted to 1% ethanol along with an
ethanol control. Separate experiments indi-
cated that this ethanol concentration had no
effect on transport activity (data not
shown). Incubations were performed in
glass petri dishes (diameter, 5 cm) in a vol-
ume of 10 mL.
Gill tissue disks were incubated in test
solutions with gentle rocking for 90 min at
15°C in the dark (n = 2–5 tissue disks per
dish). After exposure, the tissue disks were
brieﬂy washed twice in FSW to remove exter-
nal rhodamine B, frozen on dry ice or in liquid
nitrogen, and stored at –20°C in the dark. For
analysis, rhodamine B was extracted by soni-
cating the tissue in 200 µL n-butanol until
fully homogenized. n-Butanol was used for
extractions because, of the several extraction
media tested (water, phosphate-buffered saline,
some organic solvents), fluorescence signals
from rhodamine B were strongest with this sol-
vent. The sonicates were then centrifuged at
13,000g for 5 min, and the supernatant was
transferred to black 96-well microplates
(Packard Instrument Co., Meriden, CT). The
amount of dye in the supernatant was deter-
mined with a fluorescence microplate reader
(Packard FluoroCount; emission, 540 nm;
excitation, 580 nm). Rhodamine B extracts
were kept dark and on ice at all times. At each
reading, background fluorescence was deter-
mined with pure n-butanol and subtracted
from each value. Background ﬂuorescence val-
ues of gill tissue with no rhodamine added
were similar to that of the n-butanol extraction
medium.
To examine the duration of inhibitory
effects after exposure to test compounds, six to
nine gill tissue disks were incubated with
1 µM of test compounds for 2 hr. Transporter
activity was then assayed in one-third of the
disks immediately after exposure and in the
others after 24 hr and 48 hr of washing in
fresh FSW (50 mL). FSW was changed after
24 hr. During exposure and washing, dishes
were gently rocked at 15°C in the dark. The
transporter activity assay was performed with
1 µM rhodamine B as described above.
Data analysis. Transport activities in
treated gill disks were normalized relative to
nontreated controls that were run for each
individual. The ratios, which indicate rela-
tive increases in fluorescence, were used as a
measure of inhibition by each compound at
the specified concentrations. The potencies
of compounds for inhibiting MXR trans-
porter activity are calculated as concentra-
tions causing 10% and 50% of the maximal
inhibition observed for a compound (IC10
and IC50). IC10 and IC50 values were deter-
mined by probit analysis using a macro pro-
gram for Microsoft Excel written by J. Greve
(Fraunhofer-Institut für Umweltchemie und
Ökotoxikologie, Schmallenberg, Germany).
All experiments were performed at least
three times using different individuals for each
experiment, and mean values and SDs were
determined. Statistical analyses were performed
using Student’s t-test. For correlation analyses,
we determined Pearson correlation coefﬁcients.
Statistical analyses were conducted using JMP
software, version 4.0.4 (SAS Institute Inc.,
Cary, NC).
Results
Method evaluation. Biopsy punch and
extraction procedure. The biopsy punch assay
allowed processing large numbers of samples
in a standardized way to examine effects of test
compounds on efflux transporter activity in
gill tissue of mussels. After exposure to rho-
damine B and test compounds, the dye was
extracted from the biopsy tissue disks in a
deﬁned volume of solvent, and the amount of
dye was then measured ﬂuorometrically. This
approach gave results comparable with the
epifluorescence microscopy procedure of
measuring accumulation of ﬂuorescent dye in
living mussel gills (Cornwall et al. 1995;
Eufemia and Epel 1998; Galgani et al. 1996)
but was less susceptible to subjective errors
connected with the microscopic assay, such as
the selection of a tissue area to be measured.
Sample homogeneity. The use of biopsy
punches allowed us to obtain samples of
equally sized tissue disks from gills from one
individual. SDs of dry weight, protein con-
tent, and the amount of MXR transporter
P-gp (detected with antibody C219 using
Western blot techniques) varied by < 10% of
the average values in disks from the same ani-
mal (data not shown). Furthermore, we
found that transporter activity, indicated by
the amount of rhodamine B accumulated by
the tissue, was consistent among tissue disks
from the same individual (e.g., the SD from
18 disks from one individual incubated in
FSW with 1 µM rhodamine B was ± 6.5%).
Individual variation in transporter
activity. There were considerable differences
in basal efflux transporter activity between
individual animals. In control tissues, low
basal efﬂux transporter activity is indicated by
high accumulation of rhodamine B, whereas
high basal efflux activity is indicated by low
levels of rhodamine fluorescence (because
more dye is efﬂuxed from the cells). We found
that these basal rhodamine ﬂuorescence levels
varied up to 3.3-fold between individuals. A
significant correlation was found between
transporter activity and mussel size (quantiﬁed
by valve length; p = 0.003, n = 27), but there
was no relationship to sex (p = 0.32, n = 27).
These differences in basal activity also cor-
related with increased uptake of rhodamine
(and correspondingly rhodamine ﬂuorescence)
when transporter activity was maximally
repressed by an inhibitory compound. Using a
ratio of maximal ﬂuorescence to basal ﬂuores-
cence [RF(max)/F(basal)] to compare basal and
repressed transporter activity, individuals with
low basal transporter activity exhibited a low
RF(max)/F(basal), whereas animals with high basal
activity had a high ratio. For example, in a
low-activity individual with 37.3 ﬂuorescence
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whereas in a high-activity individual with 11.3
fluorescence units in the control, the
RF(max)/F(basal) was 3.8. A strong positive corre-
lation (p = 6.2 × 10–8; r2 = 0.7; n = 27) was
found for this relationship (Figure 1).
Physiologic indices and long-term expo-
sure studies. Experiments in which dissected
gill tissue was kept in FSW for 48 hr necessi-
tated an assessment of physiology over this
period. Oxygen consumption rates measured
in isolated gill tissue kept in FSW at 15°C
were stable over a period of at least 3 days.
Ciliary movement in gills was similarly stable
for 3 days (indeed, ciliary movement was
unaffected after 7 days of incubation). There
were also no evident signs of morphologic
deterioration in the tissue. Efﬂux transporter
activity tended to slightly increase over time,
as indicated by the lower amounts of rho-
damine B in control tissues. After 24 hr, ﬂuo-
rescence values were lower by an average of
8%; after 48 hr they were 13% lower than
initial values. A control was therefore run at
each time point, and activity was normalized
relative to the control tissue.
Inhibitory effects by test compounds,
dose–effect relationships. Musks and the P-gp
inhibitor reference compounds quinidine and
verapamil caused a dose-dependent increase in
accumulation of rhodamine B in mussel gill
tissue, indicating an inhibition of efﬂux trans-
porter activity. IC10 and IC50 values were
determined from the dose–effect curves (range
of tested concentrations, 0.01–100 µM for
musk compounds and quinidine, 0.001–10
µM for verapamil; using 6–11 concentrations
per series, including controls). In most cases,
curve fits (r2) of the probit regressions were
between 0.7 and 0.9. Musk concentrations
above 5–10 µM did not increase rhodamine B
ﬂuorescence, indicating maximum inhibition
of the transporter activity at these levels
(Figure 2A–F).
The IC10 values, used as indicators for low-
effect concentrations, showed clear effects in the
0.1–0.4 µM concentration range for musks and
quinidine and at 0.01 µM for verapamil
(Figure 2, Table 2). The range of IC50 values,
which were used as a measure for the inhibitory
potencies of the test compounds, was 0.7–2.6
µM for the musks and quinidine and 0.08 µM
for verapamil (Figure 2, Table 2).
The nitromusks were more effective
inhibitors than were the polycyclic musks.
When combining the values for the two musk
groups, the IC50 values for the nitromusks
(IC50 = 0.82 ± 0.53 µM, n = 11) were signiﬁ-
cantly lower than for the polycyclic musks
(IC50 = 2.34 ± 0.82 µM, n = 12; p = 0.0001,
Student’s t-test).
Combinatory effects. Synthetic musks are
usually used in combinations in fragrances,
and environmental samples often contain sev-
eral different musk compounds. We therefore
tested whether combinations of musks act in a
synergistic, antagonistic, or additive fashion in
inhibiting transporter activity. We tested treat-
ments containing a) a nitromusk mixture
(MX and MK), b) a polycyclic musk mixture
(HHCB and ADBI), and c) a nitromusk/
polycyclic musk mixture (MX and HHCB).
For these experiments, each compound was
applied at 0.5 µM to achieve a ﬁnal total con-
centration of 1 µM musks. An additional
experiment was run with a mixture of two
nitromusks (MX and MK) and two polycyclics
(HHCB and ADBI), with each compound at
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Figure 1. Correlation between basal transporter
activity [F(basal)] and relative increase in fluores-
cence in mussel gill tissue with transporter activity
inhibited maximally versus basal transporter activity
[RF(max)/F(basal)]. y = –0.07x + 3.93.
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Figure 2. Dose–effect curves for in vivo inhibition of MXR transporters in mussel gill tissue by nitromusks
[MX (A) and MK (B)], polycyclic musks [HHCB (C), ADBI (D), AHTN (E), and ATII (F)], and reference inhibitors
[verapamil (G) and quinidine (H)]. See “Materials and Methods” for details. Each curve represents data
(obtained by probit regression) from an individual animal.0.25 µM. All compounds were also tested sep-
arately at 1 µM.
In all cases, inhibition of transporter activ-
ity by mixtures of different musk compounds
was intermediate to treatments with single
compounds (Figure 3). This indicates that the
inhibitory effects of the musks in the mixtures
were additive.
Long-term inhibitory effects. We exposed
mussel gill disks to test compounds for 2 hr
and measured rhodamine uptake directly after
the exposure (0 hr) and after 24 and 48 hr of
washing the tissue in FSW. Immediately after
exposure (0 hr) we incubated a sample of the
disks in rhodamine B for 90 min; we found
rhodamine uptake to be 38–84% higher in
musk treatments compared with respective
controls because of transporter inhibition
(Figure 4A–F). After 24 hr of washing, another
sample of disks was similarly incubated in rho-
damine, and levels in the tissues previously
exposed to the musks were still 30–74% higher
than the controls, indicating continuing inhi-
bition of transporter activity. The differences
between treatments versus controls were signif-
icant for MX, HHCB, and ATII (p < 0.05,
paired t-test), and there were clear trends of
increased rhodamine levels also for MK,
ADBI, and AHTN, indicating an inhibitor-
related effect after 24 hr (Figure 4). A similar
measurement of transport activity at 48 hr
showed that activity had now reached the con-
trol levels for ATII and AHTN, indicating
complete recovery from the inhibitory action
of the musks. However, there was still a trend
of reduced activity (i.e., higher fluorescence)
for the tissues previously incubated in MX,
MK, HHCB, and ADBI. The higher ﬂuores-
cence was consistently seen with these four
compounds, indicating an inhibitory effect of
these musks even after this time period
(Figure 4).
Verapamil, a P-gp reference inhibitor,
exhibited strong long-term inhibition, indi-
cated by rhodamine tissue levels that were 88
and 35% higher than the controls at 24 and
48 hr, respectively. In contrast, a different
P-gp reference inhibitor, quinidine, showed
no long-term effects, with almost complete
reversal of inhibition seen after 24 hr of
washing (Figure 4).
Discussion
The present study shows that nitromusk and
polycyclic musk compounds inhibit the activ-
ity of efﬂux transporters in the marine mussel
Mytilus californianus and that these inhibitory
effects last for 24–48 hr after termination of
exposure to the musks. As part of this work,
we also describe an improved efflux trans-
porter assay that allows processing large num-
bers of tissue samples from one individual and
quantifying the potency of chemicals to
inhibit MXR transporter activity.
MXR efflux inhibition by musks. Both
nitromusks and polycyclic musks inhibited
efflux transporter activity, with the nitro-
musks being the more effective inhibitors.
The tested musks inhibited transporter activ-
ity at a concentration range similar to that for
quinidine but were an order of magnitude less
effective than verapamil (Figure 2, Table 2).
Furthermore, the inhibitory effects of combi-
nations of musks were additive (Figure 3).
Individual mussels differed in basal trans-
porter activity and in sensitivity to treatment
with test agents. Differences in size and age
may partly explain the variation in activity lev-
els, but the variability is likely to reflect the
heterogeneity of the natural population. Thus,
stress response levels may be determined by
genetic variation and site-speciﬁc conditions,
such as time of water immersion during tides,
wave exposure, temperature, and so forth
(Roberts et al. 1997).
Despite this variation among test animals,
differences between the different musk species
in blocking rhodamine efflux through MXR
transporters were clearly visible. These differ-
ences in inhibitory capacity most likely result
from differences in afﬁnity to substrate binding
sites of the transporter, correlated with differ-
ences in Kow (octanol–water coefﬁcient). Bain
and LeBlanc (1996) found that the inhibitory
efficiency of a chemical against human P-gp
activity was highest for moderately hydropho-
bic compounds with a log Kow in the range of
3.6–4.5. This is consistent with our data show-
ing that the nitromusks, with log Kow values of
4.3 and 4.9, were more efﬁcient inhibitors than
the more hydrophobic polycyclic musk com-
pounds, with log Kow values 5.6–6.3 (Table 1).
In fact, IC50 values for the musk compounds
were strongly correlated with respective log Kow
values (p = 0.0006, r2 = 0.9, n = 6; Figure 5),
consistent with the lower inhibitory potency of
compounds with a higher hydrophobicity.
Verapamil, which was the most effective P-gp
inhibitor in our study, also ﬁts the regression
line calculated for the musks. Quinidine, how-
ever, was less effective as an inhibitor and did
not ﬁt this regression line; consistent with its
Kow, which is below the Kow range for high-
afﬁnity P-gp substrates (Figure 5).
The sensitivity of rhodamine efﬂux to vera-
pamil, quinidine, and other known P-gp
inhibitors/substrates indicates that the MXR
phenomenon in Mytilus is associated with a
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Table 2. IC10 and IC50 values (mean ± SD) of nitro-
musks, polycyclic musks, and reference inhibitors
verapamil and quinidine for efflux transporters in
mussel gills.
IC10 IC50 n
Nitromusks
MX 0.14 ± 0.12 0.97 ± 0.63 4
MK 0.09 ± 0.12 0.74 ± 0.49 7
Polycyclic musks
HHCB 0.37 ± 0.16 2.43 ± 0.45 3
ADBI 0.39 ± 0.34 2.32 ± 1.18 3
AHTN 0.35 ± 0.31 2.05 ± 0.31 3
ATII 0.32 ± 0.04 2.56 ± 0.07 3
Verapamil 0.01 ± 0.02 0.08 ± 0.07 6
Quinidine 0.24 ± 0.20 1.59 ± 0.85 3
Data were obtained by probit regression.
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Figure 3. Inhibitory effects by musks as single compounds and in combinations as measured by retention
of rhodamine B (see “Materials and Methods” for details). Bars represent percent increase (mean ± SD)
of ﬂuorescence versus respective controls; n = 7 for experiments with solvent, 1 µM MX, 1 µM MK, 1 µM
HHCB, and 1 µM ADBI; n = 3 for MX + HHCB, MX + MK, HHCB + ADBI, and MX + MK + HHCB + ADBI.
Brackets indicate experiments that are compared.P-gp–like efflux transporter (Cornwall et al.
1995; Galgani et al. 1996; Minier et al. 1993;
Smital et al. 2003). Other transporters, such as
an MRP (Lüdeking and Köhler 2002), may be
present, but the substrate and inhibitor proﬁle
suggests a dominant activity of a P-gp type
transporter, which is most likely the target of
the musk compounds.
Long-term inhibitory effects of musks.
Inhibitory effects of musk compounds and
verapamil were still present 24–48 hr after
removal of the inhibitors (Figure 4). To our
knowledge, this is the first demonstration
of long-term inhibitory effects of MXR
modulators. These results were unexpected
because efflux transporters are involved in
removal of xenobiotics from cells; therefore,
quicker recovery of the transporter activity
would have been anticipated.
The inhibition indicates that the musks
and verapamil remain accessible to the efﬂux
transporters for 24–48 hr after removal of the
compounds from the medium. This could be
related to the hydrophobicity of the com-
pounds and/or their affinity for the trans-
porters. Hydrophobic compounds will
accumulate in the cell membrane during
exposure and could affect efflux transporters
indirectly through membrane effects (Ferté
2000), or the membranes could directly serve
as reservoirs for slow release of the chemicals,
which could then bind to the active sites of
the transporter proteins. Alternatively, the
chemicals might have a high afﬁnity for spe-
ciﬁc sites of the transporters such as substrate
binding sites or other functional sites (e.g.,
ATP-binding site) from where they are only
slowly released, with resultant long-term
inhibition.
Potential environmental relevance of syn-
thetic musks as chemosensitizers. It was first
suggested by Kurelec (1997) that environ-
mental pollutants may act as chemosensitiz-
ers by compromising the MXR system,
allowing other toxicants, which would nor-
mally be excluded by the MXR transporters,
to enter the cell. Kurelec pointed out that
chemosensitizers could include chemicals of
low toxicity, which would present an unan-
ticipated environmental or human health
risk. A broad range of anthropogenic chemi-
cals such as pesticides, pharmaceuticals, and
some polyaromatic hydrocarbons have been
found to inhibit MXR transporters by block-
ing efﬂux of ﬂuorescent or radio-labeled sub-
strates in human cells or cells of aquatic
organisms (Bain and LeBlanc 1996; Britvic
and Kurelec 1999; Cornwall et al. 1995;
Eufemia and Epel 1998; Kurelec 1992;
Smital and Kurelec 1998b; Toomey and Epel
1993). When water samples from differently
contaminated ﬁeld sites were tested for their
inhibitory potential for MXR transporters,
greater inhibition by samples containing high
levels of anthropogenic pollutants was
detected (Smital and Kurelec 1997). This
suggests that levels of anthropogenic pollu-
tants currently found in the environment
have the potential to interfere with normal
animal defense mechanisms. Recent exten-
sions of this work have shown that these MXR
chemosensitizers increased the potency of toxic
or mutagenic transporter substrates (Britvic
and Kurelec 1999; Smital and Kurelec 1998a).
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Figure 5. Correlation of MXR inhibitory efficiency
(indicated by IC50 values) and log Kow of test com-
pounds. Abbreviations: QUI, quinidine; VER, vera-
pamil. For the calculation of the regression curve,
(with 95% confidence intervals) only musk com-
pounds were included.
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Figure 4. Long-term inhibition of efﬂux transporters by nitromusks [MX (A) and MK (B)], polycyclic musks
[HHCB (C), ADBI (D), AHTN (E), and ATII (F)], and reference inhibitors [verapamil (G) and quinidine (H)].
Bars represent ﬂuorescence versus respective controls (mean % ± SD); n = 3 (11 for verapamil). 
*p < 0.05 by paired t-test.
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ControlOur data indicate that synthetic musks are
also chemosensitizers and could therefore have
indirect effects by allowing normally excluded
toxicants to permeate cells. Earlier studies have
pointed to other indirect toxic effects of nitro-
musks. For example, MK and MX both induce
P450-dependent oxygenases (Lehman-
McKeeman et al. 1995; Mersch-Sundermann
et al. 1996, 2001; Suter-Eichenberger et al.
1999) and therefore could cause increased
transformation of other environmental chemi-
cals that are mutagenic in their transformed
form such as benzo(a)pyrene, 2-amino-
anthracene, and aflatoxin B1 (Mersch-
Sundermann et al. 1996, 2001).
Do the effects of synthetic musks as MXR
inhibitors apply to real-world situations? The
concentration range in which musks are effec-
tive inhibitors [10–6–10–7 M (ppb) range] is
several orders of magnitude higher than con-
centrations reported for water samples from
the environment [10–9–10–12 M (ppt) range]
(Rimkus 1999). However, musks are concen-
trated in sediments (Winkler et al. 1998),
which could make them available to bottom
dwellers. More important, their hydrophobic-
ity results in bioaccumulation and levels in
tissues of aquatic organisms are 101- to
104-fold higher, and in the lipid fraction may
be > 105-fold above environmental levels
(Gatermann et al. 2002; Rimkus 1999).
Association with lipids may be especially rele-
vant to MXR transporters, which reside in the
cell membrane and hence are more directly
exposed to fat-soluble compounds such as the
musks. These considerations indicate that
even if ambient concentrations are low, long-
term exposure will lead to tissue burdens that
could inhibit MXR function indirectly via
membrane effects or directly via high-afﬁnity
binding to transporter sites.
The unexpected long-term effects of the
musks are troubling. One consequence of
such long-term inhibition of transporters is
that short-term events could have continuing
consequences. Thus, the effects of short-term
incidents such as storm-water runoffs or
chemical spills could continue after such
events if there is accumulation of chemo-
sensitizers in the tissue, or prolonged inhibi-
tion as a result of the acute exposure.
Musks are typically present in the environ-
ment with other contaminants (Fromme et al.
2001; Kallenborn et al. 1999) that could well
include other transporter modulators. As
shown, the effects of combinations of P-gp
inhibitors are additive, and therefore musks
could be part of a suite of pollutants that 
contribute to chemosensitizing effects in
nature. In fact, as ﬁrst suggested by Daughton
and Ternes (1999), this could be an unantici-
pated consequence of chemicals such as the
PPCPs. Additive effects of low concentrations
of many compounds could affect the MXR
transporters, and this would be magniﬁed by
the sheer numbers of different components of
the PPCPs.
Musks and other environmental chemo-
sensitizers—a human health risk? This work
on the musks, although focused on aquatic
organisms, also points to unsuspected effects
of these chemicals on human health. MXR
efﬂux pumps are widely distributed in mam-
malian tissues, where they are a crucial part
of the cellular defense against cytotoxins
(Cordon-Cardo et al. 1990). The effects of
environmental contaminants as chemo-
sensitizers have not been studied in humans;
however, inhibitors of efflux transporters
used in cancer therapy can lead to increased
permeability of healthy tissues to transporter
substrates (Luker et al. 1997), indicating that
chemosensitizers could pose a health threat.
Because synthetic musks are present in
human tissue samples, the question arises of
whether they could also be relevant as
chemosensitizers in humans. Concentrations
of MX found in body fat and breast milk are
in the range of 0.2–0.3 µmol/kg, and are in
the nanomolar range in blood plasma
(Käfferlein et al. 1998). These values represent
body burdens that are one to two orders of
magnitude below the effective concentrations
seen in the present study on mussel tissue;
however, they could contribute to additive
effects with other compounds.
The present study especially points to the
need to screen musks and other environ-
mental chemicals that accumulate in humans
to determine if they are also chemosensitizers
of MXR-related transporters. It will be espe-
cially critical to ascertain whether they cause
long-term effects similar to those seen in our
study. Effects on efﬂux systems could result in
unanticipated accumulation of toxicants in
humans and confound safety predictions of
seemingly innocuous chemicals.
REFERENCES
Api AM, Smith RL, Pipino S, Marczylo T, De Matteis F. 2004.
Evaluation of the oral subchronic toxicity of AHTN (7-acetyl-
1,1,3,4,4,6-hexamethyl-1,2,3,4-tetrahydronaphthalene) in the
rat. Food Chem Toxicol 42(5):791–801.
Bain LJ, LeBlanc GA. 1996. Interaction of structurally diverse pes-
ticides with the human MDR1 gene product P-glycoprotein.
Toxicol Appl Pharmacol 141(1):288–298.
Bain LJ, McLachlan JB, LeBlanc GA. 1997. Structure–activity rela-
tionships for xenobiotic transport substrates and inhibitory lig-
ands of P-glycoprotein. Environ Health Perspect 105:812–818.
Balk F, Blok H, Salvito D. 2001. Environmental risks of musk fra-
grance ingredients. In: Pharmaceuticals and Personal
Care Products in the Environment—Scientific and
Regulatory Issues (Daughton CG, Jones-Lepp TL, eds).
Washington, DC:American Chemical Society, 168–190.
Balk F, Ford RA. 1999a. Environmental risk assessment for the
polycyclic musks AHTN and HHCB in the EU. I. Fate and
exposure assessment. Toxicol Lett 111(1–2):57–79.
Balk F, Ford RA. 1999b. Environmental risk assessment for the
polycyclic musks, AHTN and HHCB. II. Effect assessment
and risk characterisation. Toxicol Lett 111(1–2):81–94.
Behechti A, Schramm KW, Attar A, Niederfellner J, Kettrup A.
1998. Acute aquatic toxicities of four musk xylene deriva-
tives on Daphnia magna. Water Res 32(5):1704–1707.
Bester K, Hühnerfuss H, Lange W, Rimkus GG, Theobald N. 1998.
Results of non target screening of lipophilic organic pollu-
tants in the German Bight II: polycyclic musk fragrances.
Water Res 32(6):1857–1863.
Bitsch N, Dudas C, Körner W, Failing K, Biselli S, Rimkus G,
et al. 2002. Estrogenic activity of musk fragrances
detected by the E-screen assay using human MCF-7 cells.
Arch Environ Contam Toxicol 43(3):257–264.
Breitholtz M, Wollenberger L, Dinan L. 2003. Effects of four syn-
thetic musks on the life cycle of the harpacticoid copepod
Nitocra spinipes. Aquat Toxicol 63(2):103–118.
Britvic S, Kurelec B. 1999. The effect of inhibitors of multi-
xenobiotic resistance mechanism on the production of
mutagens by Dreissena polymorpha in waters spiked with
premutagens. Aquat Toxicol 47(2):107–116.
Chou YJ, Dietrich DR. 1999a. Interactions of nitromusk parent
compounds and their amino-metabolites with the estrogen
receptors of rainbow trout (Oncorhynchus mykiss) and the
South African clawed frog (Xenopus laevis). Toxicol Lett
111(1–2):27–36.
Chou YJ, Dietrich DR. 1999b. Toxicity of nitromusks in early
lifestages of South African clawed frog (Xenopus laevis)
and zebraﬁsh (Danio rerio). Toxicol Lett 111(1–2):17–25.
Cordon-Cardo C, O’Brien JP, Boccia J, Casals D, Bertino JR,
Melamed MR. 1990. Expression of the multidrug resistance
gene product (P-glycoprotein) in human normal and tumor
tissues. J Histochem Cytochem 38(9):1277–1287.
Cornwall R, Toomey BH, Bard S, Bacon C, Jarman WM, Epel D.
1995. Characterization of multixenobiotic/multidrug transport
in the gills of the mussel Mytilus californianus and identiﬁca-
tion of environmental substrates. Aquat Toxicol 31:277–296.
Daughton CG, Ternes TA. 1999. Pharmaceuticals and personal
care products in the environment: agents of subtle change?
Environ Health Perspect 107(suppl 6):907–938.
Draisci R, Marchiafava C, Ferretti E, Palleschi L, Catellani G,
Anastasio A. 1998. Evaluation of musk contamination of
freshwater ﬁsh in Italy by accelerated solvent extraction and
gas chromatography with mass spectrometric detection.
J Chromatogr A 814(1–2):187–197.
Epel D. 1998. Use of multidrug transporters as first lines of
defense against toxins in aquatic organisms. Comp
Biochem Physiol A 120:23–28.
Epel D, Smital T. 2001. Multidrug-multixenobiotic transporters
and their signiﬁcance with respect to environmental levels
of pharmaceuticals and personal care products. In:
Pharmaceuticals and Personal Care Products in the
Environment—Scientiﬁc and Regulatory Issues (Daughton
CG, Jones-Lepp TL, eds). Washington, DC:American
Chemical Society, 244–263.
Eufemia NA, Epel D. 1998. The multixenobiotic defense mecha-
nism in mussels is induced by substrates and non-
substrates: implications for a general stress response.
Mar Environ Res 46(1–5):401–405.
Ferté J. 2000. Analysis of the tangled relationships between
P-glycoprotein-mediated multidrug resistance and the lipid
phase of the cell membrane. Eur J Biochem 267(2):277–294.
Fromme H, Otto T, Pilz K. 2001. Polycyclic musk fragrances in
different environmental compartments in Berlin
(Germany). Water Res 35(1):121–128.
Frosch PJ, Pilz B, Andersen KE, Burrows D, Camarasa JG, Dooms-
Goossens A, et al. 1995. Patch testing with fragrances: results
of a multicenter study of the European Environmental and
Contact Dermatitis Research Group with 48 frequently used
constituents of perfumes. Contact Dermatitis 33(5):333–342.
Galgani F, Cornwall R, Toomey BH, Epel DD. 1996. Interaction of
environmental xenobiotics with a multixenobiotic defense
mechanism in the bay mussel Mytilus galloprovincialis from
the coast of California. Environ Toxicol Chem 15(3):325–331.
Gatermann R, Biselli S, Hühnerfuss H, Rimkus GG, Hecker M,
Karbe L. 2002. Synthetic musks in the environment. Part 1:
Species-dependent bioaccumulation of polycyclic and
nitro musk fragrances in freshwater fish and mussels.
Arch Environ Contam Toxicol 42(4):437–446.
Käfferlein HU, Angerer J. 2001. Trends in the musk xylene con-
centrations in plasma samples from the general population
from 1992/1993 to 1998 and the relevance of dermal uptake.
Int Arch Occup Environ Health 74(7):470–476.
Käfferlein HU, Goen T, Angerer J. 1998. Musk xylene: analysis,
occurrence, kinetics, and toxicology. Crit Rev Toxicol
28(5):431–476.
Kallenborn R, Gatermann R, Rimkus GG. 1999. Synthetic musks in
environmental samples: indicator compounds with relevant
properties for environmental monitoring. J Environ Monit
1(4):70N–74N.
Article | Synthetic musk compounds as MXR inhibitors
Environmental Health Perspectives • VOLUME 113 | NUMBER 1 | January 2005 23Kester M, Bulduk S, Tibboel D, Meinl W, Glatt H, Falany C,
et al. 2000. Potent inhibition of estrogen sulfotransferase
by hydroxylated PCB metabolites: a novel pathway
explaining the estrogenic activity of PCBs. Endocrinology
141(5):1897–1900.
Kupper T, Berset JD, Etter-Holzer R, Furrer R, Tarradellas J. 2004.
Concentrations and specific loads of polycyclic musks in
sewage sludge originating from a monitoring network in
Switzerland. Chemosphere 54(8):1111–1120.
Kurelec B. 1992. The multixenobiotic resistance mechanism in
aquatic organisms. Crit Rev Toxicol 22:23–43.
Kurelec B. 1995. Reversion of the multixenobiotic resistance
mechanism in gills of marine mussel Mytilus galloprovincialis
by a model inhibitor and environmental modulators of P170-
glycoprotein. Aquat Toxicol 33:93–103.
Kurelec B. 1997. A new type of hazardous chemical: the
chemosensitizers of multixenobiotic resistance. Environ
Health Perspect 105(suppl 4):855–860.
Lehman-McKeeman LD, Caudill D, Young JA, Dierckman TA.
1995. Musk xylene induces and inhibits mouse hepatic
cytochrome P-450 2B enzymes. Biochem Biophys Res
Commun 206(3):975–980.
Liebl B, Ehrenstorfer S. 1993. Nitromoschusverbindungen in der
Frauenmilch [in German]. Gesundheitswesen 55(10):527–532.
Liu Z. 2004. Confocal laser scanning microscopy—an attractive
tool for studying the uptake of xenobiotics into plant
foliage. J Microsc 213(2):87–93.
Luckenbach T, Corsi I, Epel D. 2004. Fatal attraction: synthetic
musk fragrances compromise multixenobiotic defense
systems in mussels. Mar Environ Res 58(2–5):215–219.
Lüdeking A, Köhler A. 2002. Identiﬁcation of six mRNA sequences
of genes related to multixenobiotic resistance (MXR) and
biotransformation in Mytilus edulis. Mar Ecol-Prog Ser
238:115–124.
Luker GD, Fracasso PM, Dobkin J, Piwnica-Worms D. 1997.
Modulation of the multidrug resistance P-glycoprotein:
detection with technetium-99m-sestamibi in vivo. J Nucl
Med 38(3):369–372.
Mersch-Sundermann V, Emig M, Reinhardt A. 1996. Nitro
musks are cogenotoxicants by inducing toxifying enzymes
in the rat. Mutat Res 356(2):237–245.
Mersch-Sundermann V, Schneider H, Freywald C, Jenter C,
Parzefall W, Knasmuller S. 2001. Musk ketone enhances
benzo(a)pyrene induced mutagenicity in human derived
Hep G2 cells. Mutat Res 495(1–2):89–96.
Minier C, Akcha F, Galgani F. 1993. P-glycoprotein expression in
Crassostrea gigas and Mytilus edulis in polluted seawater.
Comp Biochem Physiol B 106(4):1029–1036.
Neyfakh AA. 1988. Use of fluorescent dyes as molecular
probes for the study of multidrug resistance. Exp Cell Res
174(1):168–176.
Osemwengi LI, Steinberg S. 2001. On-site solid-phase extrac-
tion and laboratory analysis of ultra-trace synthetic musks
in municipal sewage effluent using gas chromatography-
mass spectrometry in the full-scan mode. J Chromatogr A
932(1–2):107–118.
Ott M, Failing K, Lang U, Schubring C, Gent HJ, Georgii S, et al.
1999. Contamination of human milk in Middle Hesse,
Germany—a cross-sectional study on the changing levels
of chlorinated pesticides, PCB congeners and recent levels
of nitro musks. Chemosphere 38(1):13–32.
Paasivirta J, Sinkkonen S, Rantalainen AL, Broman D, Zebuhr Y.
2002. Temperature dependent properties of environmentally
important synthetic musks. Environ Sci Pollut Res Int
9(5):345–355.
Peck AM, Hornbuckle KC. 2004. Synthetic musk fragrances in
Lake Michigan. Environ Sci Technol 38(2):367–372.
Ricking M, Schwarzbauer J, Hellou J, Svenson A, Zitko V. 2003.
Polycyclic aromatic musk compounds in sewage treat-
ment plant effluents of Canada and Sweden: first results.
Mar Pollut Bull 46(4):410–417.
Rimkus GG. 1999. Polycyclic musk fragrances in the aquatic
environment. Toxicol Lett 111(1–2):37–56.
Rimkus GG, Butte W, Geyer HJ. 1997. Critical considerations on
the analysis and bioaccumulation of musk xylene and other
synthetic nitro musks in ﬁsh. Chemosphere 35(7):1497–1507.
Rimkus GG, Gatermann R, Hühnerfuss H. 1999. Musk xylene and
musk ketone amino metabolites in the aquatic environment.
Toxicol Lett 111(1–2):5–15.
Rimkus GG, Wolf M. 1995. Nitro musk fragrances in biota from
freshwater and marine environment. Chemosphere
30(4):641–651.
Rimkus GG, Wolf M. 1996. Polycyclic musk fragrances in
human adipose tissue and human milk. Chemosphere
33(10):2033–2043.
Roberts DA, Hofmann GE, Somero GN. 1997. Heat-shock protein
expression in Mytilus californianus: acclimatization (sea-
sonal and tidal-height comparisons) and acclimation
effects. Biol Bull 192(2):309–320.
Sanderson J, Letcher R, Heneweer M, Giesy J, van den Berg M.
2001. Effects of chloro-s-triazine herbicides and metabolites
on aromatase activity in various human cell lines and on
vitellogenin production in male carp hepatocytes. Environ
Health Perspect 109:1027–1031.
Schmeiser HH, Gminski R, Mersch-Sundermann V. 2001.
Evaluation of health risks caused by musk ketone. Int J
Hyg Environ Health 203(4):293–299.
Smital T, Kurelec B. 1997. Inhibitors of the multixenobiotic resis-
tance mechanism in natural waters: in vivo demonstration
of their effects. Environ Toxicol Chem 16(10):2164–2170.
Smital T, Kurelec B. 1998a. The activity of multixenobiotic resis-
tance mechanism determined by rhodamine B-efflux
method as a biomarker of exposure. Mar Environ Res
46(1–5):443–447.
Smital T, Kurelec B. 1998b. The chemosensitizers of multixeno-
biotic resistance mechanism in aquatic invertebrates: a
new class of pollutants. Mutat Res 399(1):43–53.
Smital T, Luckenbach T, Sauerborn R, Hamdoun AM, Vega RL,
Epel D. 2004. Emerging contaminants—pesticides, PPCPs,
microbial degradation products and natural substances as
inhibitors of multixenobiotic defense in aquatic organisms.
Mutat Res 552(1–2):101–117.
Smital T, Sauerborn R, Hackenberger BK. 2003. Inducibility of
the P-glycoprotein transport activity in the marine mussel
Mytilus galloprovincialis and the freshwater mussel
Dreissena polymorpha. Aquat Toxicol 65(4):443–465.
Suter-Eichenberger R, Boelsterli UA, Conscience-Egli M,
Lichtensteiger W, Schlumpf M. 1999. CYP 450 enzyme induc-
tion by chronic oral musk xylene in adult and developing
rats. Toxicol Lett 111(1–2):117–132.
Tas JW, Balk F. 1997. Environmental Risk Assessment of the
Polycyclic Musks AHTN and HHCB According to the
EU-TGD. RIVM Report No. 601 503 008. Bilthoven,
Netherlands:National Institute of Public Health and the
Environment.
Tas JW, Balk F, Ford RA, van de Plassche EJ. 1997. Environmental
risk assessment of musk ketone and musk xylene in the
Netherlands in accordance with the EU-TGD. Chemosphere
35(12):2973–3002.
Toomey BH, Epel D. 1993. Multixenobiotic resistance in
Urechis caupo embryos: protection from environmental
toxins. Biol Bull 185:355–364.
Wang RB, Kuo CL, Lien LL, Lien EJ. 2003. Structure-activity
relationship: analyses of P-glycoprotein substrates and
inhibitors. J Clin Pharm Ther 28(3):203–228.
White KM. 1937. Mytilus. Liverpool, UK:University Press of
Liverpool.
Winkler M, Kopf G, Hauptvogel C, Neu T. 1998. Fate of artiﬁcial
musk fragrances associated with suspended particulate mat-
ter (SPM) from the River Elbe (Germany) in comparison to
other organic contaminants. Chemosphere 37(6):1139–1156.
Wollenberger L, Breitholtz M, Ole Kusk K, Bengtsson BE. 2003.
Inhibition of larval development of the marine copepod
Acartia tonsa by four synthetic musk substances. Sci Total
Environ 305(1–3):53–64.
Yamagishi T, Miyazaki T, Horii S, Akiyama K. 1983. Synthetic musk
residues in biota and water from Tama River and Tokyo Bay
(Japan). Arch Environ Contam Toxicol 12(1):83–89.
Yamagishi T, Miyazaki T, Horii S, Kaneko S. 1981. Identiﬁcation of
musk xylene and musk ketone in freshwater ﬁsh collected
from the Tama River, Tokyo. Bull Environ Contam Toxicol
26(5):656–662.
Article | Luckenbach and Epel
24 VOLUME 113 | NUMBER 1 | January 2005 • Environmental Health Perspectives